Pedro2004
3 years ago
We have entered into an Controlled Equity Offering SM Sales Agreement (the βsales agreementβ) with Cantor Fitzgerald & Co. (βCantorβ), dated as of August 27, 2021, relating to the offer and sale of shares of our common stock. In accordance with the terms of the sales agreement, under this prospectus supplement and the accompanying prospectus, we may offer and sell shares of our common stock having an aggregate offering price of up to $17,500,000 from time to time through Cantor acting as sales agent.
Covid19freak
4 years ago
Great buying opportunity here close at ATL ,,,dirt cheap stock at $72 million valuation which has 2 phase 3 drugs with first readout expected next quarter . A potential 10 bagger and more here ..GL
Presentation October
https://investors.entasistx.com/static-files/0bf75506-2d54-4b14-896a-6a3d5ed53472
Major Shareholders
Innoviva Inc ...18.7M
Armistice ...3.5M
AstraZeneca PLC ...2.2M
Clarus Ventures, LLC ...1.3M
Pivotal ...1.2M
Sofinnova ...1.2M
Novo Holdings A/S ...1.2M
TPG Capital, L.P....1.0M
Eventide Asset ...879.5K
Frazier ...350.0K
swingingRichard
4 years ago
$ETTX Sold too early. Made only %28. The model works!!!!
HOTD (so far was $4.25). Still, I'll take 28% any day of the week. So far this year, no losing plays using the model. Now, to be fair, I did have some losing trades, things I should have just left alone after making 150%.
* * * Chart Analysis * * *